XML 13 R4.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Revenue $ 0 $ 0
Operating expenses:    
Research and development 5,130 9,377
General and administrative 7,351 10,479
Product manufacturing 7,532 1,882
Total operating expenses 20,013 21,738
Loss from operations (20,013) (21,738)
Other income 67 1,413
Interest expense on note payable to principal stockholder (721) (714)
Interest expense on notes (4,221) (9,622)
Interest income 15 3
Loss before benefit for income taxes (24,873) (30,658)
Income tax benefit 0 0
Net loss $ (24,873) $ (30,658)
Net loss per share - basic and diluted $ (0.06) $ (0.08)
Shares used to compute basic and diluted net loss per share 428,858 398,916